UBS Asset Management Americas Inc. reduced its position in Monsanto Co. (NYSE:MON) by 8.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,414,564 shares of the company’s stock after selling 132,084 shares during the period. UBS Asset Management Americas Inc. owned approximately 0.32% of Monsanto worth $144,570,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. WFG Advisors LP increased its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the period. Signaturefd LLC increased its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC increased its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC increased its position in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Finally, Enterprise Financial Services Corp increased its position in Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock valued at $138,000 after buying an additional 57 shares during the period. Institutional investors and hedge funds own 73.94% of the company’s stock.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Shares of Monsanto Co. (NYSE:MON) opened at 102.03 on Tuesday. The stock has a 50 day moving average of $100.97 and a 200-day moving average of $104.18. The firm has a market capitalization of $44.69 billion, a price-to-earnings ratio of 34.15 and a beta of 1.01. Monsanto Co. has a one year low of $83.73 and a one year high of $114.26.

Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same period in the previous year, the firm earned ($0.19) earnings per share. Monsanto’s revenue was up 8.8% compared to the same quarter last year. On average, equities analysts anticipate that Monsanto Co. will post $4.73 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright law. The original version of this news story can be viewed at https://www.thecerbatgem.com/2016/11/29/ubs-asset-management-americas-inc-has-144570000-stake-in-monsanto-co-mon.html.

Several research analysts recently weighed in on the stock. S&P Equity Research restated a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. Monness Crespi & Hardt reduced their price target on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a research report on Monday, October 3rd. Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price target for the company in a research report on Wednesday, August 3rd. TheStreet downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, September 12th. Finally, Deutsche Bank AG upped their price target on shares of Monsanto from $118.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, September 15th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $114.06.

In other Monsanto news, EVP Kerry J. Preete sold 2,745 shares of the business’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $100.96, for a total transaction of $277,135.20. Following the completion of the sale, the executive vice president now directly owns 50,056 shares in the company, valued at $5,053,653.76. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert T. Fraley sold 80,631 shares of the business’s stock in a transaction that occurred on Friday, October 14th. The stock was sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the sale, the executive vice president now owns 38,711 shares of the company’s stock, valued at $3,950,070.44. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.